Status:
COMPLETED
Cognitive Behavioral Therapy for Post Traumatic Stress Disorder in Addiction Treatment
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Stress Disorders, Post-Traumatic
Substance-Related Disorders
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this phase of the study is to further assess the efficacy of cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD), as delivered by routine addiction counselors, a...
Detailed Description
The main hypothesis being tested is that a cognitive behavioral therapy (CBT) for posttraumatic stress disorder (PTSD) can improve treatment retention and outcomes for both posttraumatic stress and su...
Eligibility Criteria
Inclusion
- At least 18 years old;
- Actively enrolled in outpatient addiction services and meets criteria for any substance use disorder;
- Screened positive for PTSD (results of PCL show a likely Criterion A Traumatic event and a score equal to or greater than 44);
- Willing and able to provide informed consent to participate in the study;
- Diagnosis of PTSD verified by the CAPS and total symptom score equal to or greater than 44;
Exclusion
- Acute psychotic symptoms (however, persons with a psychotic disorder are eligible if their symptoms are stable and they are well-connected with appropriate mental health services);
- Psychiatric hospitalization or suicide attempt in the past month (however, if the hospitalization or attempt was directly related to substance intoxication or detoxification and the person is currently stable, they are eligible);
- Medical and legal situations are unstable such that ability to participate in the full duration of the study seems unlikely.
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01456338
Start Date
June 1 2007
End Date
August 1 2009
Last Update
October 20 2011
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Dispensary
Hartford, Connecticut, United States, 06120
2
Addiction Treatment Program at DHMC
Lebanon, New Hampshire, United States, 03756
3
Farnum Center
Manchester, New Hampshire, United States, 03101
4
WestBridge
Manchester, New Hampshire, United States, 03101